Skip to main content
Clinical Trials/JPRN-UMIN000005401
JPRN-UMIN000005401Completed未知

Evaluation of effect of chemotherapy for depiction of metastatic liver tumor on gadoxetate disodium enhanced MRI - Evaluation of effect of chemotherapy on gadoxetate disodium enhanced MRI

Hiroshima University0 sites20 target enrollmentStarted: April 11, 2011Last updated:

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (a)Patients who are contraindicated in MRI examination (for example; patients with pace maker and claustrophobia patients). (b)Patients with history of severe side effect of gadolinium contrast media and gadoxetate disodium. (c)Patients with poor performance status. (d)Patients with bronchial asthma. (e)Patients with severe liver damage (Serum bilirubin > 2.0mg/dL). (f)Patients with severe kidney damage (eGFR < 30ml/min/1.73m2). (g)Gravid or lactating patients and patients who may be pregnant. (h)Patients whom their doctor decide to be inappropriate for this study.

Investigators

Similar Trials